Plasma hemostasis in hypertensive patients with concomitant non-alcoholic fatty liver disease and obesity
Saved in:
| Date: | 2018 |
|---|---|
| Main Author: | N. M. Bazhenova |
| Format: | Article |
| Language: | English |
| Published: |
2018
|
| Series: | Actual problems of transport medicine: environment, occupational health, pathology |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001027762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
The intensity of lipid distress syndrome in patients with non- alcoholic fatty liver disease on the background of obesity and chronic kidney disease (chronic pyelonephritis)
by: O. S. Khukhlina, et al.
Published: (2019)
by: O. S. Khukhlina, et al.
Published: (2019)
Liver function in patients with coronary artery disease and nonalcoholic fatty liver disease associated with obesity
by: O. Bondarenko, et al.
Published: (2017)
by: O. Bondarenko, et al.
Published: (2017)
Impact of nonalcoholic fatty liver disease on endothelium of patients with arterial hypertension and hypothyroidism
by: A. N. Belovol, et al.
Published: (2017)
by: A. N. Belovol, et al.
Published: (2017)
Genetic predictors of endothelial dysfunction and dyslipidemic patterns in patients with arterial hypertension and concomitant obesity
by: V. M. Bondar, et al.
Published: (2019)
by: V. M. Bondar, et al.
Published: (2019)
"Essel” clinical effectiveness in non-alcoholic fatty liver disease
by: O. M. Korzh, et al.
Published: (2022)
by: O. M. Korzh, et al.
Published: (2022)
Participation of polymorphism of A1166C gene of type 1 angiotensin II receptor in metabolic disorders in patients with arterial hypertension and non-alcoholic fatty liver diseases
by: Ya. Babak, et al.
Published: (2017)
by: Ya. Babak, et al.
Published: (2017)
Prospects for the use of mineral waters of different composition and mineralization in the rehabilitative treatment of patients with non-alcoholic fatty liver disease
by: I. B. Zabolotna, et al.
Published: (2018)
by: I. B. Zabolotna, et al.
Published: (2018)
Postprandial glycemia and apoproteinemia in hypertensive patients with obesity
by: O. M. Pionova
Published: (2014)
by: O. M. Pionova
Published: (2014)
Endoscopic hemostasis in bleeding from varicose veins in patients with portal hypertension
by: V. V. Bojko, et al.
Published: (2019)
by: V. V. Bojko, et al.
Published: (2019)
Ambulatory blood pressure monitoring in hypertensive patients with overweight and obesity
by: O. N. Kovaleva, et al.
Published: (2016)
by: O. N. Kovaleva, et al.
Published: (2016)
Improvement of efficiency of primary hemostasis using Sengstaken - Blakemore tube in patients with portal hypertension
by: E. V. Mogilevets, et al.
Published: (2019)
by: E. V. Mogilevets, et al.
Published: (2019)
Immune dysfunctions in patients with liver cyrrhosis with portal hypertension
by: O. F. Dzyhal, et al.
Published: (2017)
by: O. F. Dzyhal, et al.
Published: (2017)
Level of overall hemostasis potential in donor and patient plasma in pathology
by: L. V. Pyrogova, et al.
Published: (2016)
by: L. V. Pyrogova, et al.
Published: (2016)
Concomitant coronary heart disease as a factor in reducing the quality of life of patients with chronic pancreatitis
by: L. S. Babinets, et al.
Published: (2019)
by: L. S. Babinets, et al.
Published: (2019)
Polymorphism of the renin-angiotensin system genes and endothelial NO-synthase gene in obese patients with arterial hypertension
by: Ashcheulova, T.V., et al.
Published: (2018)
by: Ashcheulova, T.V., et al.
Published: (2018)
Functional myocardium assessment in patients with chronic obstructive pulmonary disease and hypertensive disease
by: V. A. Kapustnik, et al.
Published: (2017)
by: V. A. Kapustnik, et al.
Published: (2017)
Effect of antihypertensive therapy and bariatric surgery on arterial stiffness in patients with arterial hypertension and morbid obesity
by: T. V. Kolesnik, et al.
Published: (2018)
by: T. V. Kolesnik, et al.
Published: (2018)
Contractive function of gallbladder in patients with hypertonic disease on the background of overweight and obesity
by: L. M. Radchenko, et al.
Published: (2012)
by: L. M. Radchenko, et al.
Published: (2012)
Correction of haemodynamic data in advanced age patients with primary hypertension combined with coronary heart disease depending on left ventricle hypertrophy presence, obesity and multiple comorbidity
by: N. V. Tofan
Published: (2015)
by: N. V. Tofan
Published: (2015)
Immunological and biochemical disorders at osteoarthritis in combination with hypertension and obesity
by: I. G. Bereznjakov, et al.
Published: (2013)
by: I. G. Bereznjakov, et al.
Published: (2013)
On changes in the hemostasis system in oncological patients
by: O. V. Lukjanchuk, et al.
Published: (2019)
by: O. V. Lukjanchuk, et al.
Published: (2019)
Method of diagnosis nonalcoholic fatty liver in patients with type 2 diabetes mellitus
by: K. Kvit, et al.
Published: (2017)
by: K. Kvit, et al.
Published: (2017)
Effect of therapy on peripheral hemodynamic parameters in patients with arterial hypertension and morbid obesity after bariatric treatment
by: T. V. Kolesnik, et al.
Published: (2019)
by: T. V. Kolesnik, et al.
Published: (2019)
Dependence of Intestinal Microbiota Composition on Distribution and Activity of Adipose Tissue in Nonalcoholic Fatty Liver Disease
by: G. D. Fadieienko, et al.
Published: (2022)
by: G. D. Fadieienko, et al.
Published: (2022)
Overall haemostasis potential of the blood plasma and its relation to some molecular markers of the hemostasis system in patients with chronic renal disease of stage VD
by: B. G. Storozhuk, et al.
Published: (2018)
by: B. G. Storozhuk, et al.
Published: (2018)
Age features morphometric parameters of liver tissue of female white rats with chronic alcoholic liver disease and provided pathogenetic correction
by: N. A. Rykalo, et al.
Published: (2015)
by: N. A. Rykalo, et al.
Published: (2015)
Structural and functional state of the myocardium in patients with hypertension and chronic obstructive pulmonary disease
by: V. A. Kapustnik, et al.
Published: (2016)
by: V. A. Kapustnik, et al.
Published: (2016)
Features of surgical approach for concomitant abdominal and pelvic lesions of patients with polytrauma
by: P. N. Zamjatin, et al.
Published: (2019)
by: P. N. Zamjatin, et al.
Published: (2019)
Effectiveness of antihypertensive therapy in comorbidity of arterial hypertension and obesity depending on physical activity
by: V. H. Psarova, et al.
Published: (2019)
by: V. H. Psarova, et al.
Published: (2019)
Structural and functional myocardial changes in patients with chronic obstructive pulmonary disease combined with hypertension
by: V. A. Kapustnyk, et al.
Published: (2018)
by: V. A. Kapustnyk, et al.
Published: (2018)
Correction of pharmacological treatment of patients with arterial hypertension in combination with chronic obstructive pulmonary disease
by: O. M. Vlasenko, et al.
Published: (2021)
by: O. M. Vlasenko, et al.
Published: (2021)
Features of the chromosomal apparatus in patients with juvenile idiopathic arthritis with concomitant multifactorial pathology
by: N. V. Bahatska, et al.
Published: (2019)
by: N. V. Bahatska, et al.
Published: (2019)
Prediction of the development of chronic coronary heart disease in patients with metabolic syndrome at obesity considered age and gender features
by: N. Chmyr
Published: (2018)
by: N. Chmyr
Published: (2018)
Diagnostic significance of biochemical indicators of liver fibrogenesis in adolescents with obesity
by: O. V. Buznytska
Published: (2019)
by: O. V. Buznytska
Published: (2019)
Efficacy of pro- and prebiotic drugs during dysbiosis treatment of patients with pancreatitis with concomitant ascaridosis
by: L. S. Babinets, et al.
Published: (2018)
by: L. S. Babinets, et al.
Published: (2018)
Rationale for the differentiated appointment of vazoactive preparations in the treatment of patients with ischemic heart disease in combination with arterial hypertension dependent on the degree of pulmonary hypertension and / or the stage of chronic hear
by: N. A. Matsehora, et al.
Published: (2017)
by: N. A. Matsehora, et al.
Published: (2017)
Macroscopic algal growths and concomitant micromycetes
by: I. E. Dubovik, et al.
Published: (2008)
by: I. E. Dubovik, et al.
Published: (2008)
The role of G-308A variant of tumor necrosis factor-alpha gene in development of obesity in patients with coronary artery disease
by: P. H. Kravchun, et al.
Published: (2016)
by: P. H. Kravchun, et al.
Published: (2016)
Concomitant immune therapy in oncology practice
by: N. E. Prokhach, et al.
Published: (2021)
by: N. E. Prokhach, et al.
Published: (2021)
Clot formation and lysis in platelet rich plasma of healthy donors and patients with resistant hypertension
by: I. I. Patalakh, et al.
Published: (2018)
by: I. I. Patalakh, et al.
Published: (2018)
Similar Items
-
The intensity of lipid distress syndrome in patients with non- alcoholic fatty liver disease on the background of obesity and chronic kidney disease (chronic pyelonephritis)
by: O. S. Khukhlina, et al.
Published: (2019) -
Liver function in patients with coronary artery disease and nonalcoholic fatty liver disease associated with obesity
by: O. Bondarenko, et al.
Published: (2017) -
Impact of nonalcoholic fatty liver disease on endothelium of patients with arterial hypertension and hypothyroidism
by: A. N. Belovol, et al.
Published: (2017) -
Genetic predictors of endothelial dysfunction and dyslipidemic patterns in patients with arterial hypertension and concomitant obesity
by: V. M. Bondar, et al.
Published: (2019) -
"Essel” clinical effectiveness in non-alcoholic fatty liver disease
by: O. M. Korzh, et al.
Published: (2022)